Neurodegenerative Diseases Progression Markers (MARKERS-NDD)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age10+
SponsorCasa di Cura San Raffaele Cassino

About this trial

MARKERS-NDD is a prospective, observational, longitudinal study, which aims to collect data from patients affected by neurodegenerative diseases (NDD) followed longitudinally for routine examinations performed as part of normal clinical practice. Data collected from clinical evaluations, movement analysis, brain imaging, neuropsychological and electroencephalographic assessments, blood chemistry tests will be analysed to carry out statistical investigations and predictive analyses, also using artificial intelligence systems, which allow the identification of new early markers of diagnosis and prognosis of neurodegenerative diseases.

Eligibility criteria

Qualifiers

Patients with diagnosis of Parkinson's Disease, Parkinsonism and Movement Disorders

Patients with diagnosis of Parkinson's Disease

Diagnosis of Parkinson's Disease according to the United Kingdom (UK) Parkinson's Disease Society Brain Bank

Diagnosis of Movement Disorder not related to Parkinson's Disease

Disqualifiers

There are no restrictions for participation in the study based on age, severity of illness or presence of cognitive impairment, as long as the person is able to complete the research assessments.

Trial design

Treatments tested in this trial

  • Observation

Treatment groups

600 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Casa di Cura San Raffaele Cassino

Lead sponsor

IRCCS San Raffaele Roma

Collaborator

San Raffaele Telematic University

Collaborator

University of Urbino "Carlo Bo"

Collaborator

University of Cassino and Southern Lazio

Collaborator

University of Roma La Sapienza

Collaborator

Politecnico di Milano

Collaborator